Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Nivolumab 240, Hodgkin Lymphoma

Protocol-ID: 844 V2.0 (Mini), NIVO240, Hodgkin

Indication(s)

  • Hodgkin Lymphoma; ICD-10 C81.-

Links

  • Nivolumab [EMA EPAR]
  • Bristol-Myers Squibb’s Opdivo® (nivolumab) Now the First and Only FDA-Approved PD-1 Inhibitor to Offer Every Four-Week Dosing [URL]
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 12.06.2018